{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T14:00:51Z","timestamp":1774274451371,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Padres Pedal the Cause Collaborative Translational Pilot Project","award":["PCT2022"],"award-info":[{"award-number":["PCT2022"]}]},{"name":"Padres Pedal the Cause Collaborative Translational Pilot Project","award":["PTC2021"],"award-info":[{"award-number":["PTC2021"]}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1 I01 BX003856-01A1"],"award-info":[{"award-number":["1 I01 BX003856-01A1"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1 I01 BX004494-01"],"award-info":[{"award-number":["1 I01 BX004494-01"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Cancer Institute Cancer Center Support Grant","award":["P30CA23100"],"award-info":[{"award-number":["P30CA23100"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA100768"],"award-info":[{"award-number":["CA100768"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA121938"],"award-info":[{"award-number":["CA121938"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA238042"],"award-info":[{"award-number":["CA238042"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA256973-01"],"award-info":[{"award-number":["CA256973-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0675"],"award-info":[{"award-number":["W81XWH-20-1-0675"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Curebound Foundation","award":["20DG03"],"award-info":[{"award-number":["20DG03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1245\/s10434-025-16919-4","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T15:26:19Z","timestamp":1738164379000},"page":"3796-3803","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bright and Specific Targeting of Metastatic Lymph Nodes in Orthotopic Mouse Models of Gastric Cancer with a Fluorescent Anti-CEA Antibody"],"prefix":"10.1245","volume":"32","author":[{"given":"Kristin E.","family":"Cox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siamak","family":"Amirfakhri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thinzar M.","family":"Lwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojgan","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradipta","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marygorret","family":"Obonyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Yazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0086-2159","authenticated-orcid":false,"given":"Michael","family":"Bouvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"16919_CR1","unstructured":"Ferlay J EM, Lam F, Laversanne M, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Soerjomataram I, Bray F. Global Cancer Observatory: Cancer Today (version 1.1). Lyon, France: International Agency for Research on Cancer. (2024). Available at: https:\/\/gco.iarc.who.int\/today. Accessed 14 June 2024."},{"issue":"10251","key":"16919_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/s0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635\u201348. https:\/\/doi.org\/10.1016\/s0140-6736(20)31288-5.","journal-title":"Lancet"},{"issue":"14","key":"16919_CR3","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.3748\/wjg.v20.i14.3967","volume":"20","author":"JY Deng","year":"2014","unstructured":"Deng JY, Liang H. Clinical significance of lymph node metastasis in gastric cancer. World J Gastroenterol. 2014;20(14):3967\u201375. https:\/\/doi.org\/10.3748\/wjg.v20.i14.3967.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"16919_CR4","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1245\/s10434-019-07417-5","volume":"26","author":"H Mogal","year":"2019","unstructured":"Mogal H, Fields R, Maithel SK, Votanopoulos K. In patients with localized and resectable gastric cancer, what is the optimal extent of lymph node dissection-D1 versus D2 versus D3? Ann Surg Oncol. 2019;26(9):2912\u201332. https:\/\/doi.org\/10.1245\/s10434-019-07417-5.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"16919_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.surg.2014.09.012","volume":"157","author":"G Galizia","year":"2015","unstructured":"Galizia G, Lieto E, De Vita F, et al. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis. Surgery. 2015;157(2):285\u201396. https:\/\/doi.org\/10.1016\/j.surg.2014.09.012.","journal-title":"Surgery"},{"key":"16919_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2021.101689","volume":"40","author":"Y Hu","year":"2022","unstructured":"Hu Y, Yoon SS. Extent of gastrectomy and lymphadenectomy for gastric adenocarcinoma. Surg Oncol. 2022;40:101689. https:\/\/doi.org\/10.1016\/j.suronc.2021.101689.","journal-title":"Surg Oncol"},{"issue":"5","key":"16919_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/s1470-2045(10)70070-x","volume":"11","author":"I Songun","year":"2010","unstructured":"Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11(5):439\u201349. https:\/\/doi.org\/10.1016\/s1470-2045(10)70070-x.","journal-title":"Lancet Oncol"},{"issue":"11","key":"16919_CR8","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1200\/jco.2004.08.026","volume":"22","author":"HH Hartgrink","year":"2004","unstructured":"Hartgrink HH, van de Velde CJ, Putter H, et al. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol. 2004;22(11):2069\u201377. https:\/\/doi.org\/10.1200\/jco.2004.08.026.","journal-title":"J Clin Oncol"},{"issue":"10","key":"16919_CR9","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1097\/js9.0000000000000572","volume":"109","author":"SH Park","year":"2023","unstructured":"Park SH, Kim KY, Cho M, Kim YM, Kim HI, Hyung WJ. Prognostic impact of fluorescent lymphography on gastric cancer. Int J Surg. 2023;109(10):2926\u201333. https:\/\/doi.org\/10.1097\/js9.0000000000000572.","journal-title":"Int J Surg"},{"issue":"2","key":"16919_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10120-020-01121-0","volume":"24","author":"MK Jung","year":"2021","unstructured":"Jung MK, Cho M, Roh CK, et al. Assessment of diagnostic value of fluorescent lymphography-guided lymphadenectomy for gastric cancer. Gastric Cancer. 2021;24(2):515\u201325. https:\/\/doi.org\/10.1007\/s10120-020-01121-0.","journal-title":"Gastric Cancer"},{"issue":"29","key":"16919_CR11","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1200\/jco.2013.50.3789","volume":"31","author":"Y Kitagawa","year":"2013","unstructured":"Kitagawa Y, Takeuchi H, Takagi Y, et al. Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol. 2013;31(29):3704\u201310. https:\/\/doi.org\/10.1200\/jco.2013.50.3789.","journal-title":"J Clin Oncol"},{"issue":"7","key":"16919_CR12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/jso.24226","volume":"113","author":"G Herrera-Almario","year":"2016","unstructured":"Herrera-Almario G, Patane M, Sarkaria I, Strong VE. Initial report of near-infrared fluorescence imaging as an intraoperative adjunct for lymph node harvesting during robot-assisted laparoscopic gastrectomy. J Surg Oncol. 2016;113(7):768\u201370. https:\/\/doi.org\/10.1002\/jso.24226.","journal-title":"J Surg Oncol"},{"key":"16919_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.917541","volume":"12","author":"C Deng","year":"2022","unstructured":"Deng C, Zhang Z, Qi H, et al. Safety and efficacy of indocyanine green near-infrared fluorescent imaging-guided lymph nodes dissection during radical gastrectomy for gastric cancer: a systematic review and meta-analysis. Front Oncol. 2022;12:917541. https:\/\/doi.org\/10.3389\/fonc.2022.917541.","journal-title":"Front Oncol"},{"issue":"4","key":"16919_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1001\/jamasurg.2019.6033","volume":"155","author":"QY Chen","year":"2020","unstructured":"Chen QY, Xie JW, Zhong Q, et al. Safety and efficacy of indocyanine green tracer-guided lymph node dissection during laparoscopic radical gastrectomy in patients with gastric cancer: a randomized clinical trial. JAMA Surg. 2020;155(4):300\u201311. https:\/\/doi.org\/10.1001\/jamasurg.2019.6033.","journal-title":"JAMA Surg"},{"key":"16919_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12020507","author":"L Knospe","year":"2022","unstructured":"Knospe L, Gockel I, Jansen-Winkeln B, et al. New intraoperative imaging tools and image-guided surgery in gastric cancer surgery. Diagnostics (Basel). 2022. https:\/\/doi.org\/10.3390\/diagnostics12020507.","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"16919_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4253\/wjge.v15.i2.32","volume":"15","author":"C Calcara","year":"2023","unstructured":"Calcara C, Cocciolillo S, Marten Canavesio Y, et al. Endoscopic fluorescent lymphography for gastric cancer. World J Gastrointest Endosc. 2023;15(2):32\u201343. https:\/\/doi.org\/10.4253\/wjge.v15.i2.32.","journal-title":"World J Gastrointest Endosc"},{"issue":"126","key":"16919_CR17","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.5754\/hge13050","volume":"60","author":"Z Su","year":"2013","unstructured":"Su Z, Shu K, Zheng M, Sun X, Fang Z, Wang G. Sentinel lymph node and skip metastases in gastric cancer: a prospective study. Hepatogastroenterology. 2013;60(126):1513\u20138. https:\/\/doi.org\/10.5754\/hge13050.","journal-title":"Hepatogastroenterology"},{"issue":"7","key":"16919_CR18","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1245\/s10434-010-0944-0","volume":"17","author":"Y Tajima","year":"2010","unstructured":"Tajima Y, Murakami M, Yamazaki K, et al. Sentinel node mapping guided by indocyanine green fluorescence imaging during laparoscopic surgery in gastric cancer. Ann Surg Oncol. 2010;17(7):1787\u201393. https:\/\/doi.org\/10.1245\/s10434-010-0944-0.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"16919_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/SLA.0b013e3181927267","volume":"249","author":"Y Tajima","year":"2009","unstructured":"Tajima Y, Yamazaki K, Masuda Y, et al. Sentinel node mapping guided by indocyanine green fluorescence imaging in gastric cancer. Ann Surg. 2009;249(1):58\u201362. https:\/\/doi.org\/10.1097\/SLA.0b013e3181927267.","journal-title":"Ann Surg"},{"issue":"10","key":"16919_CR20","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s11605-019-04382-y","volume":"24","author":"F Cianchi","year":"2020","unstructured":"Cianchi F, Indennitate G, Paoli B, et al. The clinical value of fluorescent lymphography with indocyanine green during robotic surgery for gastric cancer: a matched cohort study. J Gastrointest Surg. 2020;24(10):2197\u2013203. https:\/\/doi.org\/10.1007\/s11605-019-04382-y.","journal-title":"J Gastrointest Surg"},{"issue":"6s","key":"16919_CR21","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/j.surg.2022.06.036","volume":"172","author":"DA Sherwinter","year":"2022","unstructured":"Sherwinter DA, Boni L, Bouvet M, et al. Use of fluorescence imaging and indocyanine green for sentinel node mapping during gastric cancer surgery: Results of an intercontinental Delphi survey. Surgery. 2022;172(6s):S29-37. https:\/\/doi.org\/10.1016\/j.surg.2022.06.036.","journal-title":"Surgery"},{"key":"16919_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.998159","volume":"12","author":"B Dong","year":"2022","unstructured":"Dong B, Zhang A, Zhang Y, Ye W, Liao L, Li Z. Efficacy of indocyanine green fluorescence imaging-guided lymphadenectomy in radical gastrectomy for gastric cancer: a systematic review and meta-analysis. Front Oncol. 2022;12:998159. https:\/\/doi.org\/10.3389\/fonc.2022.998159.","journal-title":"Front Oncol"},{"issue":"1","key":"16919_CR23","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1038\/s41467-023-42712-6","volume":"14","author":"QY Chen","year":"2023","unstructured":"Chen QY, Zhong Q, Liu ZY, et al. Indocyanine green fluorescence imaging-guided versus conventional laparoscopic lymphadenectomy for gastric cancer: long-term outcomes of a phase 3 randomised clinical trial. Nat Commun. 2023;14(1):7413. https:\/\/doi.org\/10.1038\/s41467-023-42712-6.","journal-title":"Nat Commun"},{"key":"16919_CR24","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jss.2023.08.038","volume":"293","author":"KE Cox","year":"2024","unstructured":"Cox KE, Turner MA, Amirfakhri S, et al. Humanized anti-carcinoembryonic antigen antibodies brightly target and label gastric cancer in orthotopic mouse models. J Surg Res. 2024;293:701\u20138. https:\/\/doi.org\/10.1016\/j.jss.2023.08.038.","journal-title":"J Surg Res"},{"key":"16919_CR25","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-15570-9","author":"KE Cox","year":"2024","unstructured":"Cox KE, Turner MA, Lwin TM, et al. Targeting patient-derived orthotopic gastric cancers with a fluorescent humanized anti-CEA antibody. Ann Surg Oncol. 2024. https:\/\/doi.org\/10.1245\/s10434-024-15570-9.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"16919_CR26","doi-asserted-by":"publisher","first-page":"6652","DOI":"10.21037\/tcr-20-516","volume":"9","author":"P Guazzi","year":"2020","unstructured":"Guazzi P, Zocco D, Isajevs S, et al. TM9SF4 expression in tumor tissues: a novel diagnostic biomarker for gastrointestinal tumors. Transl Cancer Res. 2020;9(11):6652\u20139. https:\/\/doi.org\/10.21037\/tcr-20-516.","journal-title":"Transl Cancer Res"},{"issue":"4","key":"16919_CR27","first-page":"2317","volume":"14","author":"K Sun","year":"2022","unstructured":"Sun K, Xu MQ, Zhang HJ, et al. Active Stat3 and Her-2 as combined survival predictors show superiority to TNM staging system for postoperative patients with gastric cancer. Am J Transl Res. 2022;14(4):2317\u201330.","journal-title":"Am J Transl Res"},{"issue":"4","key":"16919_CR28","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/ijc.2910530414","volume":"53","author":"T Furukawa","year":"1993","unstructured":"Furukawa T, Kubota T, Watanabe M, Kitajima M, Hoffman RM. Orthotopic transplantation of histologically intact clinical specimens of stomach cancer to nude mice: correlation of metastatic sites in mouse and individual patient donors. Int J Cancer. 1993;53(4):608\u201312. https:\/\/doi.org\/10.1002\/ijc.2910530414.","journal-title":"Int J Cancer"},{"issue":"5","key":"16919_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/protein\/gzh056","volume":"17","author":"PJ Yazaki","year":"2004","unstructured":"Yazaki PJ, Sherman MA, Shively JE, et al. Humanization of the anti-CEA T84.66 antibody based on crystal structure data. Protein Eng Des Sel. 2004;17(5):481\u20139. https:\/\/doi.org\/10.1093\/protein\/gzh056.","journal-title":"Protein Eng Des Sel"},{"key":"16919_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jss.2017.05.069","volume":"218","author":"JC DeLong","year":"2017","unstructured":"DeLong JC, Murakami T, Yazaki PJ, Hoffman RM, Bouvet M. Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model. J Surg Res. 2017;218:139\u201343. https:\/\/doi.org\/10.1016\/j.jss.2017.05.069.","journal-title":"J Surg Res"},{"issue":"5","key":"16919_CR31","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.21873\/invivo.12042","volume":"34","author":"HM Hollandsworth","year":"2020","unstructured":"Hollandsworth HM, Nishino H, Turner M, et al. Humanized fluorescent tumor-associated glycoprotein-72 antibody selectively labels colon-cancer liver metastases in orthotopic mouse models. In Vivo. 2020;34(5):2303\u20137. https:\/\/doi.org\/10.21873\/invivo.12042.","journal-title":"In Vivo"},{"key":"16919_CR32","doi-asserted-by":"publisher","unstructured":"Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition). Gastric Cancer. 2023;26(1):1-25. https:\/\/doi.org\/10.1007\/s10120-022-01331-8","DOI":"10.1007\/s10120-022-01331-8"},{"issue":"1","key":"16919_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5230\/jgc.2022.22.e10","volume":"22","author":"SS Eom","year":"2022","unstructured":"Eom SS, Choi W, Eom BW, et al. A comprehensive and comparative review of global gastric cancer treatment guidelines. J Gastric Cancer. 2022;22(1):3\u201323. https:\/\/doi.org\/10.5230\/jgc.2022.22.e10.","journal-title":"J Gastric Cancer"},{"issue":"10","key":"16919_CR34","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick F, Carneiro F, Cascinu S, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(10):1005\u201320. https:\/\/doi.org\/10.1016\/j.annonc.2022.07.004.","journal-title":"Ann Oncol"},{"key":"16919_CR35","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Gastric Cancer V.2.2024. National Comprehensive Cancer Network Inc. 2024. All rights reserved. Accessed June 14, 2024. www.NCCN.org."},{"issue":"5","key":"16919_CR36","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/jso.27060","volume":"126","author":"DG Coit","year":"2022","unstructured":"Coit DG, Strong VE. Fifty years of progress in gastric cancer. J Surg Oncol. 2022;126(5):865\u201371. https:\/\/doi.org\/10.1002\/jso.27060.","journal-title":"J Surg Oncol"},{"issue":"5","key":"16919_CR37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/bjs.6936","volume":"97","author":"M Degiuli","year":"2010","unstructured":"Degiuli M, Sasako M, Ponti A. Morbidity and mortality in the Italian gastric cancer study group randomized clinical trial of D1 versus D2 resection for gastric cancer. Br J Surg. 2010;97(5):643\u20139. https:\/\/doi.org\/10.1002\/bjs.6936.","journal-title":"Br J Surg"},{"issue":"2","key":"16919_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/bjs.9345","volume":"101","author":"M Degiuli","year":"2014","unstructured":"Degiuli M, Sasako M, Ponti A, et al. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg. 2014;101(2):23\u201331. https:\/\/doi.org\/10.1002\/bjs.9345.","journal-title":"Br J Surg"},{"issue":"3","key":"16919_CR39","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1097\/01.sla.0000245469.35088.42","volume":"245","author":"PC Enzinger","year":"2007","unstructured":"Enzinger PC, Benedetti JK, Meyerhardt JA, et al. Impact of hospital volume on recurrence and survival after surgery for gastric cancer. Ann Surg. 2007;245(3):426\u201334. https:\/\/doi.org\/10.1097\/01.sla.0000245469.35088.42.","journal-title":"Ann Surg"},{"issue":"2","key":"16919_CR40","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1001\/jamasurg.2018.4267","volume":"154","author":"IG Kwon","year":"2019","unstructured":"Kwon IG, Son T, Kim HI, Hyung WJ. Fluorescent lymphography-guided lymphadenectomy during robotic radical gastrectomy for gastric cancer. JAMA Surg. 2019;154(2):150\u20138. https:\/\/doi.org\/10.1001\/jamasurg.2018.4267.","journal-title":"JAMA Surg"},{"issue":"3","key":"16919_CR41","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1067\/msy.2001.111699","volume":"129","author":"M Hiratsuka","year":"2001","unstructured":"Hiratsuka M, Miyashiro I, Ishikawa O, et al. Application of sentinel node biopsy to gastric cancer surgery. Surgery. 2001;129(3):335\u201340. https:\/\/doi.org\/10.1067\/msy.2001.111699.","journal-title":"Surgery"},{"issue":"4","key":"16919_CR42","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s10120-024-01497-3","volume":"27","author":"SH Park","year":"2024","unstructured":"Park SH, Chung SY, Lee JH, et al. Feasibility of intraoperative pathologic examination for sentinel lymph nodes during sentinel node navigation surgery in early gastric cancer: results of pathologic protocol for SENORITA trial. Gastric Cancer. 2024;27(4):858\u201368. https:\/\/doi.org\/10.1007\/s10120-024-01497-3.","journal-title":"Gastric Cancer"},{"issue":"1","key":"16919_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12957-020-01834-7","volume":"18","author":"J Chen","year":"2020","unstructured":"Chen J, Zhao G, Wang Y. Analysis of lymph node metastasis in early gastric cancer: a single institutional experience from China. World J Surg Oncol. 2020;18(1):57. https:\/\/doi.org\/10.1186\/s12957-020-01834-7.","journal-title":"World J Surg Oncol"},{"issue":"10","key":"16919_CR44","doi-asserted-by":"publisher","first-page":"6959","DOI":"10.1245\/s10434-024-15642-w","volume":"31","author":"M Abate","year":"2024","unstructured":"Abate M, Drebin H, Shimada S, et al. Feasibility and efficacy of sentinel lymph node mapping in gastric cancer. Ann Surg Oncol. 2024;31(10):6959\u201369. https:\/\/doi.org\/10.1245\/s10434-024-15642-w.","journal-title":"Ann Surg Oncol"},{"key":"16919_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14205143","author":"Y Liao","year":"2022","unstructured":"Liao Y, Zhao J, Chen Y, et al. Mapping lymph node during indocyanine green fluorescence-imaging guided gastric oncologic surgery: current applications and future directions. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14205143.","journal-title":"Cancers (Basel)"},{"issue":"15","key":"16919_CR46","doi-asserted-by":"publisher","first-page":"7188","DOI":"10.7150\/thno.55389","volume":"11","author":"G Krishnan","year":"2021","unstructured":"Krishnan G, van den Berg NS, Nishio N, et al. Metastatic and sentinel lymph node mapping using intravenously delivered Panitumumab-IRDye800CW. Theranostics. 2021;11(15):7188\u201398. https:\/\/doi.org\/10.7150\/thno.55389.","journal-title":"Theranostics"},{"issue":"8","key":"16919_CR47","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/s2468-1253(20)30088-1","volume":"5","author":"G Lu","year":"2020","unstructured":"Lu G, van den Berg NS, Martin BA, et al. Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study. Lancet Gastroenterol Hepatol. 2020;5(8):753\u201364. https:\/\/doi.org\/10.1016\/s2468-1253(20)30088-1.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"16919_CR48","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.hpb.2018.11.008","volume":"21","author":"WS Tummers","year":"2019","unstructured":"Tummers WS, Miller SE, Teraphongphom NT, et al. Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical resection of pancreatic cancer. HPB (Oxford). 2019;21(7):883\u201390. https:\/\/doi.org\/10.1016\/j.hpb.2018.11.008.","journal-title":"HPB (Oxford)"},{"issue":"1045","key":"16919_CR49","doi-asserted-by":"publisher","first-page":"20140547","DOI":"10.1259\/bjr.20140547","volume":"88","author":"B Zhu","year":"2015","unstructured":"Zhu B, Sevick-Muraca EM. A review of performance of near-infrared fluorescence imaging devices used in clinical studies. Br J Radiol. 2015;88(1045):20140547. https:\/\/doi.org\/10.1259\/bjr.20140547.","journal-title":"Br J Radiol"},{"issue":"1","key":"16919_CR50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1089\/cbr.2022.0028","volume":"38","author":"JYC Wong","year":"2023","unstructured":"Wong JYC, Yamauchi DM, Adhikarla V, et al. First-In-Human Pilot PET Immunoimaging Study of (64)Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers. Cancer Biother Radiopharm. 2023;38(1):26\u201337. https:\/\/doi.org\/10.1089\/cbr.2022.0028.","journal-title":"Cancer Biother Radiopharm"},{"issue":"1","key":"16919_CR51","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1089\/cbr.2019.2992","volume":"35","author":"D Akhavan","year":"2020","unstructured":"Akhavan D, Yazaki P, Yamauchi D, et al. Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic antigen humanized antibody in patients with advanced carcinoembryonic antigen producing malignancies. Cancer Biother Radiopharm. 2020;35(1):10\u20135. https:\/\/doi.org\/10.1089\/cbr.2019.2992.","journal-title":"Cancer Biother Radiopharm"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-16919-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-16919-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-16919-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T06:22:13Z","timestamp":1744093333000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-16919-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["16919"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-16919-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RMH is a nonsalaried affiliate of AntiCancer, Inc. producing patient-derived orthotopic xenograft mouse models for contract research. PY declares a patent covering the anti-CEA M5A antibody for fluorescence guided surgery.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}